Company Filing History:
1 out of 167 
1 out of 189 Years Active: 2020
Title: The Innovative Contributions of Susan Hoppmann
Introduction
Susan Hoppmann is a notable inventor based in Amersham, GB. She has made significant contributions to the field of medical imaging and cancer monitoring. Her work focuses on the development of innovative polypeptides that can aid in the detection and treatment of tumors.
Latest Patents
Susan Hoppmann holds a patent for HER2 polypeptides useful for imaging and monitoring tumors and cancers. This patent describes a method of using an isolated polypeptide conjugated with a radionuclide. The isolated polypeptide specifically binds to HER2 or its variants. The method is designed for monitoring the response to HSP90 inhibition and involves the use of the isolated polypeptide conjugated with 18F. Additionally, the application outlines the use of this isolated polypeptide as an imaging agent to monitor uptake and measure HSP90 inhibition.
Career Highlights
Throughout her career, Susan has worked with prominent companies such as Imperial Innovations Limited and GE Healthcare Limited. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the medical field.
Collaborations
Susan has collaborated with notable individuals in her field, including Duncan Robert R Hiscock and Eric Ofori Aboagye. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Susan Hoppmann's contributions to medical imaging and cancer monitoring through her innovative patents highlight her role as a leading inventor in her field. Her work continues to impact the way tumors and cancers are monitored and treated.